Feedback / Questions
vobarilizumab (ALX-0061) - Sanofi
Ablynx: FY 2014 Results
(Ablynx)
-
Feb 28, 2015 -
"ALX-0061 - key milestones in clinical development"; "Phase I sc study"; "ALX-0061 showed >80% bioavailability after sc injection"
P1 data
•
Rheumatoid Arthritis
http://www.ablynx.com/wp-content/uploads/2015/02/Webcast-FY-2014-results_150226_FINAL.pdf
Feb 28, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.